Stock Track | AdvisorShares Pure US Cannabis ETF Plummets 13.31% Intraday as Cannabis Rally Fades on Narrow Rescheduling Scope

Stock Track04-24

The AdvisorShares Pure US Cannabis ETF (MSOS) experienced a significant decline intraday, with its price plummeting 13.31%.

The sharp drop followed a sector-wide reversal, as initial investor enthusiasm for a U.S. policy shift on cannabis gave way to concerns over its limited scope. The U.S. Department of Justice moved to reschedule FDA-approved and state-licensed marijuana from Schedule I to Schedule III, but industry participants noted the order applies specifically to a narrow segment rather than the broader market.

This realization led to a pullback across cannabis shares, with major companies slumping in afternoon trading. The rescheduling, while significant, was seen as creating uneven benefits and doing little to resolve longstanding structural issues facing the industry, such as conflicts between federal and state law and broader legal and financial barriers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment